United States· US:57894-449_5900ea09-1687-4d73-912f-5b0527cba6be

TECVAYLI

A teclistamab product containing teclistamab, registered in United States by Janssen Biotech, Inc.. The same ATC class is registered in 14 of our 19 countries.

ATC L01FX24US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTECVAYLIATCL01FX24REGISTER NO.US:57894-449_5900ea09…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Teclistamab is registered in 14 of 19 countries.

Countries holding a registration under ATC L01FX24 (teclistamab), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Teclistamab · ATC L01FX24

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TECLISTAMAB
Manufacturer
Janssen Biotech, Inc.
Country
United States (US)
ATC code
L01FX24
ATC class
Teclistamab
Defined daily dose
15 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5789444901
    1 VIAL, SINGLE-DOSE in 1 CARTON (57894-449-01) / 3 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    57894-449-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Teclistamab in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All teclistamab products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Tecvayli
  • Liechtenstein · Tecvayli
  • Norway · Tecvayli

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa644b3f-aba7-46e8-bf77-0f882ca15095
GET /v1/drugs/aa644b3f-aba7-46e8-bf77-0f882ca15095?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "source": "ndc",
  "strength": "10",
  "substance": "TECLISTAMAB",
  "productndc": "57894-449",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "BLA761291",
  "marketing_category": "BLA"
}

See everything about teclistamab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.